Info banner

A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Category: Medmonitor

83 posts found

FDA Accepts New Drug Application for Opioid NKTR-181

NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?

Phase 2/3 clinical trial results for Korsuva demonstrate pain relief with fewer side effects.

The FDA recently approved drugs to treat opioid dependence, migraines, and rheumatoid arthritis.

A newly released draft guidance encourages the development of more sustained-release buprenorphine products.

If approved, Lucemyra (lofexidine) would be the first non-opioid drug approved to treat the symptoms of opioid withdrawal.

Apadaz oral tablets were approved for the short-term management of acute pain, at no more than 14 days of use.

Senna Laxative bottles were found to contain NSAIDs, while 55 lots of compounded drugs face questionable sterility.

FDA, opioid, opioids, opioid policy, opioid policies, drug development, non-opioid

Prev 1 2 3 4 5 6